Truist Securities Maintains Buy on SI-BONE, Lowers Price Target to $16

Benzinga · 10/14 14:25
Truist Securities analyst Samuel Brodovsky maintains SI-BONE (NASDAQ:SIBN) with a Buy and lowers the price target from $18 to $16.